Postapproval Changes for Drugs: A Practical Guide
vi
Table 20-2. MAH Reporting Requirements........................................................................................ 228
Table 20-3. Methods for Communicating Safety Issues. .....................................................................233
Table 22-1. National Pharmacovigilance Centers in Africa ................................................................251
Abbreviations and Acronyms. ................................................................................................................267
Glossary of Terms................................................................................................................................... 273
Index...................................................................................................................................................... 279
vi
Table 20-2. MAH Reporting Requirements........................................................................................ 228
Table 20-3. Methods for Communicating Safety Issues. .....................................................................233
Table 22-1. National Pharmacovigilance Centers in Africa ................................................................251
Abbreviations and Acronyms. ................................................................................................................267
Glossary of Terms................................................................................................................................... 273
Index...................................................................................................................................................... 279